Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
According to a report in India’s Economic Times, AuthBridge sifted through three years of applicant data from over 500 companies and found that pharma/clinical trials is among the industries with the “highest employee discrepancies”.
The trend is said to be most common among the 30-49 age groups, when “the applicant doesn’t mind enriching his or her educational qualification,” says AuthBridge CEO, Ajay Trehan.
He goes on: “One candidate had furnished the educational qualifications of his ex-boss, another had used her deceased sister’s credentials while applying for a job.”
Pharma sector hiring grew by 24% last year compare with 2012, according to a report by headhunting firm Randstad. But most of the recent hires in senior positions are from outside the industry, noted a spokesperson for a large Indian pharma firm, because there is uncertainty about the quality of people available in the current market. In areas such as R&D, however, research and development, there are no options but to look for those within the industry. As a result, this particular executive’s firm has “tightened investigation of our potential employees.”
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.